July 25, 2019 M&A, Partnerships PR/Corporate Process Analytical Instr.

908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

07.25.19 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announced it has been awarded a technical project grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). This award will fuel continued development of simple, at-line bioreactor process analytics – a collaboration between 908 Devices, MilliporeSigma, the University of North Carolina at Chapel... Read more

July 25, 2019 Clinical Research/Diagn. Informatics & Software Product Launch

Cytel launches East On Demand bringing adaptive clinical trial design capabilities to wider biopharma audience

Cambridge, MA, July 25, 2019 – Cytel Inc., the leading global provider of analytical solutions to the life sciences industry, today announced that it will launch East On Demand™ at the annual Joint Statistical Meetings (JSM) 2019 (July 27 – August 1, Denver, Colorado). Offered via the cloud and licensed through subscriptions, East On Demand provides statisticians with... Read more

July 24, 2019 Licensing, IP, and Legal

Delaware District Court Grants Bio-Rad’s Motion for Permanent Injunction Against 10X Genomics

ate: 07/24/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announces that today the Delaware District Court granted Bio-Rad’s motion for permanent injunction against 10X Genomics from making any sales of infringing products to new customers and granting Bio-Rad’s request for supplemental damages and... Read more

July 23, 2019 M&A, Partnerships

SAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene Therapies

evo® Cold Chain Management System and LifeGuard Same Day Service Reduce Risks for High-Value, Temperature-Sensitive Biologic Drugs BOTHELL, Wash., July 23, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that SAVSU Technologies, a leading developer of advanced cold chain... Read more

July 23, 2019 Clinical Research/Diagn. M&A, Partnerships

Uman Diagnostics and Bio-Techne Announce License and Supply Agreement for Neurofilament Light Assay

JULY 23, 2019 MINNEAPOLIS, July 23, 2019 /PRNewswire/ — Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne... Read more

July 22, 2019 Environ, Ag./Food & Bev M&A, Partnerships

Neogen awarded USDA contract

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., July 22, 2019 — Neogen Corporation (NASDAQ: NEOG) announced today that it had again been awarded the contract to supply certain dehydrated culture media to the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS). The FSIS uses Neogen Culture Media to monitor raw and ready-to-eat meat... Read more

July 18, 2019 Lab Top-10 Life Science Tools M&A, Partnerships

Merck KGaA, Darmstadt, Germany and Broad Institute Announce CRISPR License Framework to Encourage Innovation

18 JUL 2019 | DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the Broad Institute of MIT and Harvard today announced an agreement between Broad Institute and the Life Science business of Merck KGaA, Darmstadt, Germany to offer non-exclusive licenses... Read more

July 18, 2019 PR/Corporate

Harvard Bioscience Names Michael Rossi Chief Financial Officer

HOLLISTON, Mass., July 18, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Michael Rossi has been named Chief Financial Officer, effective immediately.  Rossi most recently served as Chief Financial Officer of Laborie Medical Technologies, a global medical devices company. Jim Green, Chairman, President and CEO stated, “Mike Rossi’s deep experience in finance, public company accounting, global business operations,... Read more

July 17, 2019 Liq. Handling & Robotics Product Launch

Bio-Techne Releases 32×8 Cartridge For The Ella Platform

JULY 17, 2019 MINNEAPOLIS, July 17, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8-Plex cartridge format for the ProteinSimple™-branded Ella™ automated immunoassay platform. This new cartridge format analyzes 32 samples for eight distinct analytes, bringing higher multiplex capabilities to the Ella platform. The 32×8 cartridge for Ella enables users... Read more

July 17, 2019 Licensing, IP, and Legal Life Science Tools

Oxford Nanopore prevails for fourth time in patent hearing

Wed 17th July 2019 Oxford Nanopore has prevailed once again following the decision yesterday by the European Patent Office (EPO) to revoke a second PacBio European Patent, EP3170904. This decision is consistent with that of an earlier EPO decisionrevoking PacBio European Patent EP3045542, as well as rulings from the ITC and US Court of Appeal that the claims of the... Read more